Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hyperlipoproteinemias

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    May 2021
  1. HOCH VL, Lin KH, Soffer D, Stone NJ, et al
    A "rule of thumb" aids evaluation of severe hypercholesterolemia to recognize familial hypercholesterolemia.
    Am J Med. 2021 May 25. pii: S0002-9343(21)00328.
    PubMed    


    April 2021
  2. ELBADAWI A, Elgendy IY, Omer M, Abdelazeem M, et al
    Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia.
    Am J Med. 2021 Apr 16. pii: S0002-9343(21)00226.
    PubMed     Abstract available


  3. MASON RP, Eckel RH
    Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction.
    Am J Med. 2021 Apr 14. pii: S0002-9343(21)00227.
    PubMed     Abstract available


    February 2021
  4. BAE SS, Chang LC, Merkin SS, Elashoff D, et al
    Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.
    Am J Med. 2021;134:243-251.
    PubMed     Abstract available


    January 2021
  5. ARBEL R, Aboalhasan E, Hammerman A, Azuri J, et al
    Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia-Value for Money Analysis.
    Am J Med. 2021 Jan 12. pii: S0002-9343(21)00021.
    PubMed     Abstract available


    November 2020
  6. ALDER M, Bavishi A, Zumpf K, Peterson J, et al
    A Meta-Analysis Assessing Additional LDL-C Reduction from Addition of a Bile Acid Sequestrant to Statin Therapy.
    Am J Med. 2020;133:1322-1327.
    PubMed     Abstract available


    June 2020
  7. CHAMBERLAIN AM, Boyd CM, Manemann SM, Dunlay SM, et al
    Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.
    Am J Med. 2020;133:e237-e248.
    PubMed     Abstract available


  8. GILLESPIE CW, Morin PE, Tucker JM, Purvis L, et al
    Medication Adherence, Health Care Utilization, and Spending Among Privately Insured Adults With Chronic Conditions in the United States, 2010-2016.
    Am J Med. 2020;133:690-704.
    PubMed     Abstract available


  9. HAXHI J, Bote J, Thompson PD
    Acute Pancreatitis After a Meatless Burger in Familial Chylomicronemia Syndrome.
    Am J Med. 2020;133:e308.
    PubMed    


    April 2020
  10. CLAXTON JS, Chamberlain AM, Lutsey PL, Chen LY, et al
    Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 years and older with Atrial Fibrillation.
    Am J Med. 2020 Apr 19. pii: S0002-9343(20)30344.
    PubMed     Abstract available


    January 2020
  11. DANA AP, Kazory A
    Spurious Low Serum Bicarbonate Level due to Severe Hypertriglyceridemia - A Clinical Challenge.
    Am J Med. 2020 Jan 9. pii: S0002-9343(20)30007.
    PubMed    


  12. SALVATORE T, Morganti R, Marchioli R, De Caterina R, et al
    Cholesterol Lowering and Stroke: No Longer Room for Pleiotropic Effects of Statins - Confirmation from PCSK9 Inhibitor Studies.
    Am J Med. 2020;133:95-99.
    PubMed     Abstract available


    December 2019
  13. MCKIE PM, Kor DJ, Cook DA, Kessler ME, et al
    Computerized Advisory Decision Support for Cardiovascular Diseases in Primary Care: A Cluster Randomized Trial.
    Am J Med. 2019 Dec 17. pii: S0002-9343(19)31083.
    PubMed     Abstract available


    November 2019
  14. ROH JW, Chun KH, Kang M, Lee CJ, et al
    PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching.
    Am J Med. 2019;132:1320-1326.
    PubMed     Abstract available


    February 2019
  15. ARPS K, Pallazola VA, Cardoso R, Meyer J, et al
    Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2.
    Am J Med. 2019 Feb 1. pii: S0002-9343(19)30140.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: